{"id":"https://openalex.org/W4307339156","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","title":"90Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor","display_name":"90Y-Labeled Gold Nanoparticle Depot (NPD) Combined with Anti-PD-L1 Antibodies Strongly Inhibits the Growth of 4T1 Tumors in Immunocompetent Mice and Induces an Abscopal Effect on a Distant Non-Irradiated Tumor","publication_year":2022,"publication_date":"2022-10-26","ids":{"openalex":"https://openalex.org/W4307339156","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","pmid":"https://pubmed.ncbi.nlm.nih.gov/36287201"},"language":"en","primary_location":{"id":"doi:10.1021/acs.molpharmaceut.2c00572","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074856879","display_name":"Zhongli Cai","orcid":"https://orcid.org/0000-0002-8937-4943","observed_orcids":["https://orcid.org/0000-0002-8937-4943"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Zhongli Cai","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada"],"raw_orcid":"https://orcid.org/0000-0002-8937-4943","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042882163","display_name":"Rella Liu","orcid":"https://orcid.org/0000-0002-1078-2806","observed_orcids":["https://orcid.org/0000-0002-1078-2806"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Rella Liu","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada"],"raw_orcid":"https://orcid.org/0000-0002-1078-2806","affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069657541","display_name":"Conrad Chan","orcid":"https://orcid.org/0009-0001-3099-1082","observed_orcids":["https://orcid.org/0009-0001-3099-1082"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Conrad Chan","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031882165","display_name":"Yijie Lu","orcid":"https://orcid.org/0000-0002-0192-5270","observed_orcids":["https://orcid.org/0000-0002-0192-5270"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Yijie Lu","raw_affiliation_strings":["Department of Chemistry, University of Toronto, Toronto, OntarioM5S 3H6, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Toronto, Toronto, OntarioM5S 3H6, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026093276","display_name":"Mitchell A. Winnik","orcid":"https://orcid.org/0000-0002-2673-2141","observed_orcids":["https://orcid.org/0000-0002-2673-2141"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Mitchell A. Winnik","raw_affiliation_strings":["Department of Chemistry, University of Toronto, Toronto, OntarioM5S 3H6, Canada"],"raw_orcid":"https://orcid.org/0000-0002-2673-2141","affiliations":[{"raw_affiliation_string":"Department of Chemistry, University of Toronto, Toronto, OntarioM5S 3H6, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060911347","display_name":"David W. Cescon","orcid":"https://orcid.org/0000-0002-1080-0998","observed_orcids":["https://orcid.org/0000-0002-1080-0998"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"David W. Cescon","raw_affiliation_strings":["Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2C1, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2C1, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023465589","display_name":"Raymond M. Reilly","orcid":"https://orcid.org/0000-0003-1038-7993","observed_orcids":["https://orcid.org/0000-0003-1038-7993"]},"institutions":[{"id":"https://openalex.org/I1325899441","display_name":"University Health Network","ror":"https://ror.org/042xt5161","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441"]},{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I2802654988","display_name":"Princess Margaret Cancer Centre","ror":"https://ror.org/03zayce58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Raymond M. Reilly","raw_affiliation_strings":["Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, Toronto, OntarioM5S 1A8, Canada","Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada","Joint Department of Medical Imaging and Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2C1, Canada"],"raw_orcid":"https://orcid.org/0000-0003-1038-7993","affiliations":[{"raw_affiliation_string":"Department of Medical Imaging, Temerty Faculty of Medicine, University of Toronto, Toronto, OntarioM5S 1A8, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College St., Toronto, OntarioM5S 3M2, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Joint Department of Medical Imaging and Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 2C1, Canada","institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I2802654988"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5023465589"],"corresponding_institution_ids":["https://openalex.org/I1325899441","https://openalex.org/I185261750","https://openalex.org/I2802654988"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":1.8487,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.84553993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"19","issue":"11","first_page":"4199","last_page":"4211"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9247999787330627,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9247999787330627,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.020500000566244125,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11176","display_name":"Radiation Therapy and Dosimetry","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.8640000224113464},{"id":"https://openalex.org/keywords/abscopal-effect","display_name":"abscopal effect","score":0.8939999938011169},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.6740000247955322},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.6399999856948853},{"id":"https://openalex.org/keywords/absorbed-dose","display_name":"absorbed dose","score":0.7979999780654907},{"id":"https://openalex.org/keywords/normal-tissue-toxicity","display_name":"normal tissue toxicity","score":0.6380000114440918},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.6269999742507935},{"id":"https://openalex.org/keywords/immunocompetent-mice","display_name":"immunocompetent mice","score":0.6790000200271606},{"id":"https://openalex.org/keywords/beta-emitters","display_name":"beta emitters","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6794371604919434},{"id":"https://openalex.org/C2781274730","wikidata":"https://www.wikidata.org/wiki/Q4669679","display_name":"Abscopal effect","level":4,"score":0.6017315983772278},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5341179966926575},{"id":"https://openalex.org/C21269302","wikidata":"https://www.wikidata.org/wiki/Q7243098","display_name":"Primary and secondary antibodies","level":3,"score":0.4922408163547516},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.476815402507782},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4725201725959778},{"id":"https://openalex.org/C104819515","wikidata":"https://www.wikidata.org/wiki/Q900961","display_name":"Colloidal gold","level":3,"score":0.4510648548603058},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.42944246530532837},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.39750438928604126},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3614963889122009},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.32519274950027466},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2693483233451843},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.23274105787277222},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.22450727224349976},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.16753658652305603},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.14001095294952393},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10622727870941162}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006046","descriptor_name":"Gold","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053768","descriptor_name":"Metal Nanoparticles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1021/acs.molpharmaceut.2c00572","doi":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","is_oa":false,"landing_page_url":"https://doi.org/10.1021/acs.molpharmaceut.2c00572","pdf_url":null,"source":{"id":"https://openalex.org/S204562082","display_name":"Molecular Pharmaceutics","issn_l":"1543-8384","issn":["1543-8384","1543-8392"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Pharmaceutics","raw_type":"journal-article"},{"id":"pmid:36287201","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36287201","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular pharmaceutics","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320319928","display_name":"Canadian Cancer Society","ror":null},{"id":"https://openalex.org/F4320334593","display_name":"Natural Sciences and Engineering Research Council of Canada","ror":"https://ror.org/01h531d29"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W287605918","https://openalex.org/W1551407310","https://openalex.org/W1559871492","https://openalex.org/W1965225327","https://openalex.org/W1990753829","https://openalex.org/W2022837929","https://openalex.org/W2025000901","https://openalex.org/W2053725511","https://openalex.org/W2070780645","https://openalex.org/W2072212283","https://openalex.org/W2089519905","https://openalex.org/W2097103399","https://openalex.org/W2108789863","https://openalex.org/W2108935762","https://openalex.org/W2137289789","https://openalex.org/W2140231263","https://openalex.org/W2142604595","https://openalex.org/W2159094759","https://openalex.org/W2266862084","https://openalex.org/W2268448293","https://openalex.org/W2274421140","https://openalex.org/W2302383556","https://openalex.org/W2511964116","https://openalex.org/W2512274829","https://openalex.org/W2527196273","https://openalex.org/W2547723079","https://openalex.org/W2562574147","https://openalex.org/W2764338877","https://openalex.org/W2783003100","https://openalex.org/W2886119834","https://openalex.org/W2965639414","https://openalex.org/W2979722259","https://openalex.org/W2989593825","https://openalex.org/W3007730713","https://openalex.org/W3020983734","https://openalex.org/W3026025471","https://openalex.org/W3032578076","https://openalex.org/W3033869790","https://openalex.org/W3104676857","https://openalex.org/W3107982397","https://openalex.org/W3137730516","https://openalex.org/W3203791623","https://openalex.org/W3210773054","https://openalex.org/W4223510207","https://openalex.org/W4223965717"],"related_works":["https://openalex.org/W2268448293","https://openalex.org/W2581061958","https://openalex.org/W4396644643","https://openalex.org/W3133336821","https://openalex.org/W3138043955","https://openalex.org/W3182644379","https://openalex.org/W4224228672","https://openalex.org/W4235016393","https://openalex.org/W2612726266","https://openalex.org/W7172444433"],"abstract_inverted_index":{"The":[0,124],"effectiveness":[1],"and":[2,43,71,153,188,243,346,359,368,393,423],"normal":[3,245,317],"tissue":[4,318],"toxicity":[5,319,348],"of":[6,33,89,168,179,197,222,376,416],"a":[7,25,50,72,362,382,403],"novel":[8],"nanoparticle":[9],"depot":[10],"(NPD)":[11],"brachytherapy":[12],"seed":[13],"incorporating":[14,86,135,145,159,185,203,335,378],"gold":[15],"nanoparticles":[16],"(AuNPs)":[17],"labeled":[18],"with":[19,57,64,84,103,157,183,201,284,299,333,395,435],"\u03b2-particle":[20],"emitting,":[21],"90":[22,90,136,160,186,223,336,379],"Y":[23,224],"(termed":[24],"\u201cradiation":[26],"nanomedicine\u201d),":[27],"were":[28,76,151,259,307,341,351],"studied":[29],"for":[30,44,113,250,261,312,412],"the":[31,81,166,169,180,198,226,238,262,272,281,295,302,413],"treatment":[32,178,415],"4T1":[34,67,369,384],"triple-negative":[35,417],"murine":[36],"mammary":[37],"carcinoma":[38],"tumors":[39,420],"in":[40,80,225,237,244,271,280,291,329,355,386,421],"Balb/c":[41,62,387],"mice":[42,63,331,388],"inducing":[45],"an":[46,399],"abscopal":[47,400],"effect":[48,212,401],"on":[49,213,402],"distant":[51,73,404],"non-irradiated":[52,430],"tumor":[53,70,75,83,126,173,182,200,215,228,240,264,274,283,344,370,385,391],"alone":[54,100,120,150,209],"or":[55,97,101,116,121,206],"combined":[56,102,394,434],"anti-PD-L1":[58,106,118,155,194,207,396],"immune":[59],"checkpoint":[60,436],"antibodies.":[61,195],"two":[65],"subcutaneous":[66],"tumors\u2500a":[68],"primary":[69,82,125,170,181,199,227,263,282,383],"secondary":[74,214,239,273,405],"implanted":[77,230],"intratumorally":[78],"(i.t.)":[79],"NPD":[85,134,144,158,184,202,334,377],"3.5":[87],"MBq":[88],"Y-AuNPs":[91,137,161,380],"(1":[92],"\u00d7":[93],"10":[94],"14":[95,131],"AuNPs)":[96],"unlabeled":[98,146,204],"AuNPs,":[99],"systemically":[104],"administered":[105],"antibodies":[107,119,149,156,208,397],"(200":[108],"\u03bcg":[109],"i.p.":[110],"three":[111],"times/week":[112],"2":[114],"weeks)":[115],"received":[117],"no":[122,211],"treatment.":[123],"was":[127,175,191,278,320,361],"strongly":[128,389],"growth-inhibited":[129],"over":[130],"d":[132],"by":[133,143,177,193],"but":[138,233,267,322],"only":[139],"very":[140,234,268],"modestly":[141],"inhibited":[142,176,390],"AuNPs.":[147],"Anti-PD-L1":[148],"ineffective,":[152],"combining":[154],"did":[162],"not":[163,347],"further":[164],"inhibit":[165],"growth":[167,174,189,392],"tumor.":[171,406],"Secondary":[172],"Y-AuNPs,":[187],"inhibition":[190],"enhanced":[192],"Treatment":[196],"AuNPs":[205],"had":[210],"growth.":[216],"Biodistribution":[217],"studies":[218],"showed":[219],"high":[220,255,287],"uptake":[221,236],"[516\u2013810%":[229],"dose/g":[231],"(%ID/g)]":[232],"low":[235,269,308],"(0.033\u20130.16%":[241],"ID/g)":[242,248],"tissues":[246],"(<0.5%":[247],"except":[249,311],"kidneys":[251,313],"(5\u20138%":[252],"ID/g).":[253],"Very":[254],"radiation":[256,408],"absorbed":[257],"doses":[258,270,285,306],"estimated":[260],"(472":[265],"Gy)":[266,310],"(0.13":[275],"Gy).":[276,315],"There":[277],"highdose-heterogeneity":[279],"as":[286,288,343],"9964":[289],"Gy":[290],"close":[292],"proximity":[293],"to":[294,429],"NPD,":[296],"decreasing":[297],"rapidly":[298],"distance":[300],"from":[301],"NPD.":[303],"Normal":[304],"organ":[305],"(<1":[309],"(4":[314],"No":[316],"observed,":[321],"white":[323],"blood":[324],"cell":[325],"counts":[326,340,367],"(WBC)":[327],"decreased":[328],"tumor-bearing":[330],"treated":[332],"Y-AuNPs.":[337],"Decreased":[338],"WBC":[339,366],"interpreted":[342],"response":[345],"since":[349],"these":[350,424],"higher":[352],"than":[353],"that":[354,374],"healthy":[356],"non-tumor-bearing":[357],"mice,":[358],"there":[360],"direct":[363],"association":[364],"between":[365],"burden.":[371],"We":[372],"conclude":[373],"implantation":[375],"into":[381],"induced":[398],"This":[407],"nanomedicine":[409],"is":[410],"promising":[411],"local":[414],"breast":[418],"cancer":[419],"patients,":[422],"therapeutic":[425],"effects":[426],"may":[427],"extend":[428],"lesions,":[431],"especially":[432],"when":[433],"immunotherapy.":[437]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":9}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-10-31T00:00:00"}